Company Search:
Advanced Search
Sponsored Links
Vaccibody AS Company Snapshot
Vaccibody AS operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vaccibody AS with three other miscellaneous service companies in Europe: Pharma Mar SA of SPAIN (2020 sales of 269.96 million Euros [US$316.11 million] of which 95% was Biotech Sector), Basilea Pharmaceutica Limited of SWITZERLAND (112.42 million Swiss Francs [US$121.53 million] ), and Oxford BioMedica plc which is based in UNITED KINGDOM (£87.73 million [US$120.01 million] of which 99% was Platform).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vaccibody AS
  Stock Performance Chart for Vaccibody AS
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): 69.00
(Figures in Norwegian Kroner)
1 Week -2.7%   13 Weeks -9.4%  
4 Weeks -13.6%   52 Weeks 86.5%  
Vaccibody AS Key Data:
  Ticker: VACC Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 2,013,862,000
(Year Ending Jan 2021).
Employees: 51
  Currency: Norwegian Kroner Market Cap: 19,771,525,305
  Fiscal Yr Ends: December Shares Outstanding: 286,543,845
  Share Type: Ordinary Closely Held Shares: 180,605,510
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.